Browsing Tag
New Jersey
98 posts
Can PJM’s new rules for data center integration prevent a reliability shortfall across its 13-state grid?
PJM outlines new 2026 plan to manage large load growth and prevent grid shortfalls. Find out how data centers and LSEs must adapt under new rules.
How a $50,000 fund by Provident Bank just took a punch at food insecurity – and what it means for community banking
Find out how Provident Bank’s new crisis response fund is fighting food insecurity and reshaping community support strategies today.
Williams wins key permits for $1bn NESE pipeline project as it aims to reshape New York’s gas supply
Williams secures state permits for $1B Northeast Supply Enhancement gas pipeline, reviving a key project amid energy affordability concerns.
Why did Becton Dickinson appoint Vitor Roque as interim CFO, and what’s next for BDX stock?
Becton Dickinson (NYSE: BDX) names Vitor Roque as interim CFO as Christopher DelOrefice exits. Find out what this means for BDX’s strategy and investor sentiment.
Can Bristol Myers Squibb’s $1.5bn Orbital deal make in-vivo CAR-T the next big breakthrough in autoimmune care?
Bristol Myers Squibb’s $1.5 B Orbital buyout bets on in-vivo CAR-T and RNA delivery to reshape autoimmune care. Find out what it means for BMY investors.
Why Eos Energy’s 7.33m-share filing could reshape its stock outlook in 2025
Eos Energy Enterprises files to sell 7.33M shares. Learn how the equity raise impacts dilution, growth runway, and EOSE stock sentiment.
Hudson tunnel project secures $665mn contract extension as MPA Delivery Partners push transformational U.S. rail milestone
MPA Delivery Partners secures $665M extension for the Hudson Tunnel Project, reinforcing U.S. rail renewal and boosting Parsons and Arcadis stocks.
Why Merck’s MSD is paying up to $600m for Evaxion’s undisclosed vaccine candidate EVX-B3
MSD licenses Evaxion’s AI-discovered vaccine EVX-B3 with $7.5M upfront and up to $592M in milestones—why this risky biotech bet could redefine vaccines.
How Celltrion’s $330m Eli Lilly deal positions it for a new era of U.S. biomanufacturing
Celltrion’s $330M purchase of Eli Lilly’s U.S. plant signals a tariff-proof pivot in biosimilars, reshaping pharma manufacturing in the U.S. today.
Stretch Zone brings practitioner-assisted stretching to Bedminster with new studio launch
Discover how Stretch Zone’s new Bedminster studio is redefining wellness with practitioner-assisted stretching and fueling rapid franchise growth.